Breaking
Medicus Pharma Ltd. to Present at Biotech Showcase 2026, Advancing SkinJect ProgramEli Lilly's Legal Victory Over Noom's GLP-1 ClaimsBBSW AI Solution Event: Daily Roundup
Saturday, July 11, 2026
🇺🇸 FDA

nipocalimab-aahu News

🇺🇸 FDA ← All news

FDA nipocalimab-aahu coverage for business development, investment, and market access teams

Critical impact NewsApr 28, 2026

FDA Grants Priority Review for IMAAVY (Nipocalimab-aahu) as First Potential Treatment for Warm Autoimmune Hemolytic Anemia

FDA · Autoimmune Hematology · 3 min

Michael Rivera

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.